Browse Drug Recalls
207 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 207 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 207 FDA drug recalls in CT.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Jul 13, 2015 | Intermezzo (zolpidem tartrate), sublingual tablet 3.5 mg, 1 tablet per pouch,... | Failed dissolution specifications | Class III | Purdue Pharma L.P. |
| Jun 2, 2014 | Soliris (eculizumab), 300 mg/30 mL (10 mg/mL), 30 mL Single-Use Vial, Rx only... | Presence of Particulate Matter: Product failed the appearance for the presence of visible particl... | Class I | Alexion Pharmaceuticals, Inc. |
| Nov 22, 2013 | Dollar General Triple Antibiotic Ointment; NET WT 1 OZ (28 g), OTC, DISTRIBU... | Microbial Contamination of Non-Sterile Products: Elevated counts of gram positive rods were found... | Class II | Faria Limited LLC dba Sheffield Pharmaceuticals |
| Nov 22, 2013 | FAMILY wellness Triple Antibiotic Ointment. NET WT 1 OZ (28 g), OTC, DISTRIBU... | Microbial Contamination of Non-Sterile Products: Elevated counts of gram positive rods were found... | Class II | Faria Limited LLC dba Sheffield Pharmaceuticals |
| Nov 22, 2013 | Dr. Sheffield Triple Antibiotic Ointment, OTC a) 0.33 oz (9g) (NDC 11527-162-... | Microbial Contamination of Non-Sterile Products: Elevated counts of gram positive rods were found... | Class II | Faria Limited LLC dba Sheffield Pharmaceuticals |
| Nov 4, 2013 | Soliris (eculizumab) Concentrated Solution for Intravenous Infusion Only, 300... | Presence of Particulate Matter: Failed the appearance test for the presence of visible particles. | Class I | Alexion Pharmaceuticals, Inc. |
| May 28, 2013 | Dr. Sheffield's Triple Antibiotic Ointment Bacitracin 400 units, Neomycin Sul... | Failed Stability Specifications: Unable to meet shelf life expiry. | Class III | Faria Limited LLC dba Sheffield Pharmaceuticals |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.